Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-14-018925
Filing Date
2014-05-06
Accepted
2014-05-06 10:49:57
Documents
1
Period of Report
2014-05-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 5962
  Complete submission text file 0001140361-14-018925.txt   7345
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Issuer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02452
Business Address
Hunt Anthony (Reporting) CIK: 0001606030 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-14656 | Film No.: 14815764